Literature DB >> 2661283

MHC molecules and beta-cell destruction. Immune and nonimmune mechanisms.

L C Harrison1, I L Campbell, J Allison, J F Miller.   

Abstract

Hyperexpression of major histocompatibility complex (MHC) molecules by islet cells is a prominent, early feature of islet pathology in insulin-dependent diabetes mellitus and concomitant with beta-cell failure after exposure of islets to specific cytokines or viruses. The transgenic expression of a class I MHC gene (H-2Kb) in the beta-cells of either syngeneic or allogeneic mice leads to beta-cell failure by a nonimmune mechanism. Several class II MHC transgenes, with one exception, have the same effect, but the expression of other transgenes that have products that are membrane proteins is not necessarily detrimental. Class I MHC molecules have been shown to interact directly with other membrane proteins. The inappropriate expression of MHC molecules could therefore interfere with key cellular functions. We postulate that the hyperexpression of MHC molecules in the beta-cell, e.g. in response to viruses, is a primary, nonimmune mechanism of beta-cell failure that precedes a secondary autoimmune response.

Entities:  

Mesh:

Year:  1989        PMID: 2661283     DOI: 10.2337/diab.38.7.815

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

Review 1.  Genetic analysis of susceptibility to type 1 diabetes.

Authors:  J A Todd
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  Interferon alpha: The key trigger of type 1 diabetes.

Authors:  Angela Lombardi; Effie Tsomos; Sara S Hammerstad; Yaron Tomer
Journal:  J Autoimmun       Date:  2018-08-14       Impact factor: 7.094

Review 3.  The immunologic insult in type 1 diabetes.

Authors:  M C Honeyman; L C Harrison
Journal:  Springer Semin Immunopathol       Date:  1993

4.  Constitutive and regulated expression of the class IB molecule Qa-1 in pancreatic beta cells.

Authors:  T Chun; C J Aldrich; M E Baldeón; L V Kawczynski; M J Soloski; H R Gaskins
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

5.  Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype.

Authors:  A G Geiser; J J Letterio; A B Kulkarni; S Karlsson; A B Roberts; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

6.  Nonimmune thyroid destruction results from transgenic overexpression of an allogeneic major histocompatibility complex class I protein.

Authors:  A G Frauman; P Chu; L C Harrison
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

7.  Autoimmune diabetes-prone NOD mice express the Lyt2 alpha (Lyt2.1) and Lyt3 alpha (Lyt3.1) alleles of CD8.

Authors:  J M Johnson-Tardieu; E W Walworth; J G Cornelius; X Ye; S M Schuster; A B Peck
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

Review 8.  Cytokines and autoimmunity.

Authors:  M G Cavallo; P Pozzilli; R Thorpe
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

9.  Mumps virus infects beta cells in human fetal islet cell cultures upregulating the expression of HLA class I molecules.

Authors:  P Parkkonen; H Hyöty; L Koskinen; P Leinikki
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

10.  Enhanced expression of MHC class I molecules on cultured human thyroid follicular cells infected with reovirus through induction of type 1 interferons.

Authors:  M S Atta; W L Irving; R J Powell; I Todd
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.